“This is going to be much more of a morass than people think,” said Marilyn Moon, director of the health program at the American Institutes for Research and a former trustee of the Social Security and Medicare trust funds. Negotiating drug prices is “a feel-good kind of answer, but it’s not one that is easy to imagine how you put into practice.”

Read more on this topic.